Mary Reumuth

Track

Insider profile

Currently holds a position at KALA BIO Inc

Performance

Overall performance
3.6
Performance over holding periods
3.6
30 days 90 days 120 days
Average return 25% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
2 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Chief Financial Officer, Treasurer KALA BIO Inc July 1, 2017 -
Senior Vice President - Finance KALA BIO Inc Feb. 1, 2017 - July 1, 2017
Vice President - Finance, Corporate Controller KALA BIO Inc None -
Mary Reumuth's trades of KALA BIO Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-10-24 2025-10-23
US KALA BIO Inc (KALA)
S Sale
39,676 -0.5%
243.88
US$1,688,142 		39,676 -0.5% 243.88 US$1,688,142
2025-10-23 2025-10-23
US KALA BIO Inc (KALA)
PrS Proposed sale
37,508
298.67
US$4,195,078 		37,508 298.67 US$4,195,078
2025-10-24 2025-10-22
US KALA BIO Inc (KALA)
S Sale
52,230 +43.6%
153.50
US$1,949,302 		52,230 +43.6% 153.50 US$1,949,302
2025-10-22 2025-10-22
US KALA BIO Inc (KALA)
PrS Proposed sale
32,230
0.83
US$26,728 		32,230 0.83 US$26,728
2025-06-26 2025-06-24
US KALA BIO Inc (KALA)
PlS Planned sale
3,631 -5.5%
4.01
US$14,560 		3,631 -5.5% 4.01 US$14,560
2025-06-24 2025-06-24
US KALA BIO Inc (KALA)
PrS Proposed sale
3,631
4.01
US$14,560 		3,631 4.01 US$14,560
2025-06-04 2025-06-03
US KALA BIO Inc (KALA)
PlS Planned sale
2,850 -4.2%
3.74
US$10,659 		2,850 -4.2% 3.74 US$10,659
2025-01-07 2025-01-06
US KALA BIO Inc (KALA)
PlS Planned sale
1,706 -2.4%
7.63
US$13,017 		1,706 -2.4% 7.63 US$13,017
2024-06-27 2024-06-26
US KALA BIO Inc (KALA)
PlS Planned sale
4,163 -6.5%
4.75
US$19,774 		4,163 -6.5% 4.75 US$19,774
2024-06-24 2024-06-24
US KALA BIO Inc (KALA)
PrS Proposed sale
3,897
4.90
US$19,092 		3,897 4.90 US$19,092
2024-06-03 2024-05-31
US KALA BIO Inc (KALA)
PlS Planned sale
1,786 -2.7%
6.09
US$10,877 		1,786 -2.7% 6.09 US$10,877
2024-01-05 2024-01-04
US KALA BIO Inc (KALA)
PlS Planned sale
1,227 -1.8%
6.74
US$8,270 		1,227 -1.8% 6.74 US$8,270
2023-01-06 2023-01-04
US KALA BIO Inc (KALA)
PlS Planned sale
60 -0.5%
28.54
US$1,712 		60 -0.5% 28.54 US$1,712
2022-10-28 2022-10-26
US KALA BIO Inc (KALA)
PlS Planned sale
194 -7.4%
6.51
US$1,263 		194 -7.4% 6.51 US$1,263
2022-06-29 2022-06-27
US KALA BIO Inc (KALA)
PlS Planned sale
2,613 -2.0%
0.37
US$967 		2,613 -2.0% 0.37 US$967
2022-01-05 2022-01-04
US KALA BIO Inc (KALA)
PlS Planned sale
2,850 -2.1%
1.30
US$3,705 		2,850 -2.1% 1.30 US$3,705
2021-10-28 2021-10-26
US KALA BIO Inc (KALA)
PlS Planned sale
9,449 -6.5%
1.80
US$17,008 		9,449 -6.5% 1.80 US$17,008
2021-06-29 2021-06-28
US KALA BIO Inc (KALA)
PlS Planned sale
2,452 -1.7%
5.77
US$14,148 		2,452 -1.7% 5.77 US$14,148